Skip to search.
 All Ordinaries Down 1.07%

More On IPD.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Impedimed Ltd (IPD.AX)

-ASX
0.89 Up 0.01(0.56%) 3 Jul 15:52
Add to Portfolio
Prev Close:0.89
Open:0.89
Bid:0.89
Ask:0.90
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.89 - 0.89
52wk Range:0.19 - 1.00
Volume:40,320
Avg Vol (3m):430,301
Market Cap:261.03M
P/E (ttm):N/A
EPS (ttm):-0.05
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in AUD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):64.95
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.04
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.3
PEG Ratio (5 yr expected):-271.88

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImpediMed Limited develops, manufactures, and sells bioimpedance and bioimpedance spectroscopy devices, and consumables for clinicians and allied health professionals in Australia, Canada, Mexico, The United States, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback